Guardian Pharmacy Services (GRDN) Earnings Analysis

Guardian Pharmacy Services (GRDN) next reports earnings on 2026-08-06, consensus EPS 0.26 USD. Last quarter (2026-03-11) it beat with EPS 0.37 USD vs 0.27 USD est (+37%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 46.79.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GRDN next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.26 USD
Revenue estimate0.34B

GRDN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-110.37 USD0.27 USD+37%Beat
2025-11-100.25 USD0.24 USD+4.2%Beat
2025-08-110.23 USD0.22 USD+4.5%Beat
2025-05-120.21 USD0.22 USD-4.5%Miss
2024-08-220.245 USDn/an/an/a

Beat rate: 3/4 (75%) over reported quarters with consensus data.

GRDN valuation and analyst view

Trailing P/E46.79
Trailing EPS0.83805 USD
Price / book11.40
Dividend yield0.00%
Market cap2.52B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)
Avg price target47 USD

Related research pages

Frequently asked questions

When is Guardian Pharmacy Services (GRDN)'s next earnings date?

Guardian Pharmacy Services is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.26 USD and revenue estimate of 0.34B.

Did GRDN beat earnings last quarter?

In its 2026-03-11 report, GRDN posted EPS of 0.37 USD versus a 0.27 USD estimate — a beat of 37%.

What is GRDN's earnings track record?

Over the last 4 reported quarters with consensus data, GRDN beat estimates 3 times (75%).

What is GRDN's current P/E ratio and EPS?

GRDN trades at a trailing P/E of 46.79 on trailing EPS of 0.8380474092323242 USD.

What do analysts rate GRDN?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 47 USD.